SCHEMBL3344619

SCHEMBL3344619

Cc1ccc(-c2ccn[nH]c2=O)cc1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
TSHR P16473 1/20 0.50
PDE3B Q13370 4/20 0.43
PDE3A Q14432 4/20 0.43
P2RX7 Q99572 1/20 0.39
ALDH1A1 P00352 4/20 0.38
MAPT P10636 3/20 0.38
KDM4E B2RXH2 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HPGD P15428 2/20 0.38
PKM P14618 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
CYP3A4 P08684 2/20 0.38
AURKB Q96GD4 2/20 0.38
INCENP Q9NQS7 2/20 0.38
NTRK1 P04629 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3342950 0.81 BRD4 (0.43) LMNAPDE3BPDE3AP2RX7ALDH1A1
SCHEMBL3344611 0.81 BTK (0.46) P2RX7TDP1
SCHEMBL3340311 0.78 NOTUM (0.36) LMNATSHRPDE3BPDE3AP2RX7
SCHEMBL1226692 0.77 ALDH1A1 (0.42) LMNAP2RX7ALDH1A1MAPTKDM4E
SCHEMBL5070318 0.76 KDR (0.41) LMNAPDE3BPDE3AALDH1A1MAPT
SCHEMBL2473305 0.76 KMT2A (0.42) LMNAALDH1A1KDM4ENPC1RAB9A
SCHEMBL2326304 0.75 NOTUM (0.40) PDE3BPDE3AP2RX7ALDH1A1KDM4E
SCHEMBL1226389 0.74 P2RX7 (0.41) LMNATSHRPDE3BPDE3AP2RX7
SCHEMBL3342855 0.73 LMNA (0.48) LMNATSHRPDE3BPDE3AALDH1A1
SCHEMBL11265687 0.72 NOTUM (0.59) MAPTKDM4EPKMMEN1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435990-B2 Dihydropyrimidone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2013-05-07 US disclosed
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS BROTHERTON-PLEISS CHRISTINE E 2011-02-03 US disclosed
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 LMNA 2330/4885TSHR 1051/4885PDE3B 1330/4885
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX7, P2RX3 LMNA 2432/4885TSHR 462/4885PDE3B 1350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.